Adeno-associated virus serotypes 1 to 5 mediated tumor cell directed gene transfer and improvement of transduction efficiency

This publication has 39 references indexed in Scilit:

• A Phase II, Double-Blind, Randomized, Placebo-Controlled Clinical Trial of tgAAVCF Using Maxillary Sinus Delivery in Patients with Cystic Fibrosis with Antrostomies
  Human Gene Therapy, 2002
• Adeno-Associated Viral Vectors Penetrate Human Solid Tumor TissueIn VivoMore Effectively than Adenoviral Vectors
  Human Gene Therapy, 2002
• Role of Interfacial Hydrophobic Residues in the Stabilization of the Leucine Zipper Structures of the Transcription Factors c-Fos and c-Jun
  Journal of Biological Chemistry, 2002
• Building a Better Vector: The Manipulation of AAV Virions
  Virology, 2000
• AAV vectors: is clinical success on the horizon?
  Gene Therapy, 2000
• Cancer gene therapy: hard lessons and new courses
  Gene Therapy, 2000
• αVβ5 integrin: a co-receptor for adeno-associated virus type 2 infection
  Nature Medicine, 1999
• Recombinant Adeno-Associated Virus for the Generation of Autologous, Gene-Modified Tumor Vaccines: Evidence for a High Transduction Efficiency into Primary Epithelial Cancer Cells
  Human Gene Therapy, 1998
• Nucleotide Sequencing and Generation of an Infectious Clone of Adeno-Associated Virus 3
  Virology, 1996
• Cloning of adeno-associated virus into pBR322: rescue of intact virus from the recombinant plasmid in human cells.
  Proceedings of the National Academy of Sciences, 1982